Cash and Short Term Investments (Annual) Chart

View Cash and Short Term Investments (Annual) for SLNCF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Annual) Chart
Start Trial

Historical Cash and Short Term Investments (Annual) Data

View and export this data back to 1996. Start Trial.
Date Value
December 31, 2025 85.11M
December 31, 2024 147.33M
December 31, 2023 68.79M
December 31, 2022 85.58M
December 31, 2021 99.60M
December 31, 2020 51.19M
December 31, 2019 44.40M
December 31, 2018 33.80M
December 31, 2017 58.25M
December 31, 2016 48.21M
December 31, 2015 76.51M
December 31, 2014 34.08M
December 31, 2013 34.60M
December 31, 2012 14.48M
December 31, 2011 5.790M
Date Value
December 31, 2010 5.584M
December 31, 2009 1.827M
December 31, 2008 4.817M
December 31, 2007 20.25M
December 31, 2006 17.27M
December 31, 2005 15.61M
December 31, 2004 5.053M
December 31, 2003 9.117M
December 31, 2002 11.53M
December 31, 2001 13.21M
December 31, 2000 17.07M
December 31, 1999 16.97M
December 31, 1998 6.091M
December 31, 1997 8.529M
December 31, 1996 11.47M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Annual) Range, Past 5 Years

View Cash and Short Term Investments (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Annual) Benchmarks

View Cash and Short Term Investments (Annual) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc 11.48M
NuCana Plc 32.62M
Mereo BioPharma Group Plc 40.99M
Compass Pathways Plc 149.99M
HemoGenyx Pharmaceuticals Plc 2.134M